leisure time -WSS

leisure time

author：comprehensive 2025-09-28 21:11:19 - browse：43533

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Celebrate National Dole Whip Day for 3 days this week at Disney

entertainment

focus

WSS

Digital health: a case of mistaken identity

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Medical experts are missing from AI regulatory conversations

Seattle police shoot person suspected in downtown stabbing

H5N1 virus can be tracked in retail milk, scientists say

Fentanyl is making it harder to start addiction treatment

hotspot

leisure time

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

At flashy new research hub, AstraZeneca lays out ambitious growth goals

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Duchenne breakthrough therapy leaves behind pioneering families

TikTok cracks down on users posting about weight loss drugs

Supreme Court strikes down use of affirmative action

Investigation reveals sickle cell patients pressured into sterilizations

Alkermes shareholders re

Stanford updates investigation of president’s past research

Wikipedia

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

For longer

H5N1 bird flu outbreak: Second human case reported, in Michigan

Making the case for fair compensation in clinical trials

H5N1 bird flu outbreak: Second human case reported, in Michigan

focus

entertainment

focus

knowledge